Product Information
TOPIRAMATE ER 50 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.1331 per EA under NDC 00480235701. Its NADAC has been published 161 times since Jul 26, 2023.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480235701
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA206210FDA Approved
3/10/2023
TE Code
AB1
On Market Since
5/3/2023
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 50 MG CAPSULE has been published 161 times since Jul 26, 2023, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1331 per EA |
|---|---|
| All-time high | $11.6059 (Aug 16, 2023) |
| All-time low | $5.3769 (Nov 20, 2024) |
| 52-week high | $6.7514 |
| 52-week low | $5.7954 |
| Median price | $6.8703 |
| Average price | $7.3337 |
| Largest weekly change | -28.1% (Feb 21, 2024) |
| Weeks tracked | 161 |
| Tracking since | Jul 26, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $6.1331 per EA (NDC 00480235701), effective Aug 19, 2026.
How has the price of TOPIRAMATE ER 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has declined 47.2%. It has been tracked across 161 weekly CMS publications since Jul 26, 2023.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG CAPSULE?
Since Jul 26, 2023, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has ranged from a low of $5.3769 (Nov 20, 2024) to a high of $11.6059 (Aug 16, 2023), with a median of $6.8703 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 50 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 50 MG SPRINKL CAP, is $3.3778 per EA — about 45% below TOPIRAMATE ER 50 MG CAPSULE.
Who manufactures TOPIRAMATE ER 50 MG CAPSULE?
TOPIRAMATE ER 50 MG CAPSULE (NDC 00480235701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.